person
as of 2026-07-01Gary Remington, MD PhD FRCPC
Gary Remington, MDGary J Remington, MD, PhDGary Remington, MD, PhDGary J. Remington, MD, PhD
ORCID 0000-0001-9433-9416
at a glance
Roles: Principal Investigator, Author, Investigator+Author
KOL signal score 12
3 publications · 2 high-value
Synthesized from structured facts only — each point cited above.
Profile
Affiliation
Centre for Addiction and Mental Health
Roles
Principal Investigator, Author, Investigator+Author
KOL signal
12
Publications
3 (2 high-value)
Trial investigator
yes
Trials led
7
Tetrabenazine for Partial Responders
NCT00362804—Completed
Antipsychotic Medication Extended Dosing Study
NCT00431574—Completed
Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia
NCT02639702Phase 4Recruiting
"Extended" (Alternate Day) Antipsychotic Dosing
NCT04478838Phase 4Recruiting
Antipsychotic Augmentation With L-Dopa
NCT01636037Phase 2Completed
Switching Antipsychotics: Abrupt Discontinuation Versus Overlap
NCT02640300Phase 4Completed
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
NCT00917293Phase 2Terminated
Publications & congress
3
Virtual Reality for the Treatment of Auditory Hallucinations in Schizophrenia Spectrum Disorders: a Systematic Review and Meta-Analysis.
Schizophrenia bulletin · 2026 · high-value
The Immediate and Sustained Effects of Multi-Session Biparietal Transcranial Direct Current Stimulation on Insight in Schizophrenia.
Schizophrenia bulletin · 2026 · high-value
Prevalence of antipsychotic polypharmacy in patients with schizophrenia and other psychotic disorders in the MENAT and EMRO countries: a systematic review and meta-analysis.
Frontiers in psychiatry · 2026
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here